ストックスクリーナーアプリを入手
14.95
5.26%
0.78
前日終値:
$14.17
開ける：
$14.51
24時間の取引高:
18,699
Relative Volume:
0.03
時価総額：
$8.15M
収益：
-
当期純損益:
$-9.60M
株価収益率:
-4.731
EPS:
-3.16
ネットキャッシュフロー:
$-8.96M
1週間 パフォーマンス:
-1.75%
1か月 パフォーマンス:
+153.66%
6か月 パフォーマンス:
+113.52%
1年 パフォーマンス:
+78.84%
1日の値動き範囲:
$14.51
$16.44
1週間の範囲:
$12.67
$16.44
52週間の値動き範囲:
$4.9176
$28.60
Artelo Biosciences Inc Stock (ARTL) Company Profile
名前
Artelo Biosciences Inc
セクター
電話
858-925-7049
住所
505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA
ARTL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARTL
Artelo Biosciences Inc
|
14.91 | 11.32M | 0 | -9.60M | -8.96M | -3.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.29 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.80 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.34 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
570.41 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.31 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-08 | アップグレード | D. Boral Capital | Hold → Buy |
| 2021-02-12 | 開始されました | Ladenburg Thalmann | Buy |
Artelo Biosciences Inc (ARTL) 最新ニュース
Artelo Biosciences Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com
Is Artelo Biosciences Inc. a good long term investmentFree Real-Time Stock Data - Autocar Professional
What drives Artelo Biosciences Inc. stock priceFree Expert Stock Watchlist - jammulinksnews.com
What analysts say about Artelo Biosciences Inc. stockConsistently superior profits - jammulinksnews.com
What makes Artelo Biosciences Inc. stock price move sharplyStable Stocks With High Yield - Newser
Artelo Biosciences Announces $6.5 Million At-The-Market Offering Agreement - AInvest
Artelo Biosciences' ATM Offering: A Delicate Balance Between Liquidity and Dilution - AInvest
Artelo Biosciences Announces At-The-Market Offering Agreement - TipRanks
What analysts say about Artelo Biosciences Inc. stock outlookMinimized Risk Maximum Return - Newser
Artelo Biosciences: KDJ Golden Cross, Bullish Marubozu on 15-Minute Chart - AInvest
Why Artelo Biosciences Inc. stock attracts strong analyst attentionFree Join Group - Newser
How Artelo Biosciences Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
Artelo Biosciences Plummets Over 22%—What's Driving the Freefall? - AInvest
Artelo Biosciences Stock Soars 114% After Promising Depression Treatment Data - MSN
Artelo Biosciences Shares Climb on Promising Preclinical Osteoarthritis Pain Data - MSN
Artelo Biosciences Plans to Offer 920K Shares of Common Stock - AInvest
Artelo Biosciences completes reverse stock split and reports preliminary Q2 financials - Investing.com Nigeria
D. Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Buy - Defense World
D Boral Capital Upgrades Artelo Biosciences (NASDAQ:ARTL) to Strong-Buy - Defense World
Artelo Biosciences presents positive data for arthritis pain drug By Investing.com - Investing.com South Africa
Artelo Biosciences stock soars after positive preclinical pain data By Investing.com - Investing.com Nigeria
Artelo Biosciences stock soars after positive preclinical pain data - Investing.com
Artelo Biosciences Announces Positive Preclinical Efficacy Data for Art26.12 in Osteoarthritis Pain At the 35Th Annual International Cannabinoid Research Society Symposium - MarketScreener
Artelo Biosciences announces preclinical efficacy results of ART26.12 - TipRanks
Artelo Biosciences Soars 30.5% on Promising Depression Drug Data - AInvest
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society Symposium - The Manila Times
Artelo Biosciences Inc (ARTL) 財務データ
収益
当期純利益
現金流量
EPS
4.56%
0.33%
大文字化:
|
ボリューム (24 時間):